|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.88 USD | +1.37% |
|
+11.46% | +36.43% |
| Market Cap | 2.69B 2.33B 2.17B 1.99B 3.74B 256B 3.8B 25.49B 10B 128B 10.09B 9.87B 427B | P/E 2026 * |
16.7x | P/E 2027 * | -14.8x |
|---|---|---|---|---|---|
| Enterprise Value | 1.74B 1.51B 1.41B 1.29B 2.42B 166B 2.46B 16.5B 6.47B 82.95B 6.53B 6.39B 276B | EV / Sales 2026 * |
2.3x | EV / Sales 2027 * | 14.9x |
| Free-Float |
98.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Nurix Therapeutics, Inc.
| 1 day | +1.37% | ||
| 1 week | +11.46% | ||
| Current month | +11.50% | ||
| 1 month | +12.23% | ||
| 3 months | +56.66% | ||
| 6 months | +57.33% | ||
| Current year | +36.43% |
| 1 week | 24.54 | 26.04 | |
| 1 month | 21.23 | 26.04 | |
| Current year | 14.01 | 26.04 | |
| 1 year | 8.2 | 26.04 | |
| 3 years | 4.22 | 29.56 | |
| 5 years | 4.22 | 37.42 | |
| 10 years | 4.22 | 52.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Arthur Sands
CEO | Chief Executive Officer | 64 | 2014-09-17 |
Hans van Houte
DFI | Director of Finance/CFO | 60 | 2016-02-29 |
Seema Rogers
CTO | Chief Tech/Sci/R&D Officer | - | 2019-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Arthur Sands
BRD | Director/Board Member | 64 | 2014-09-17 |
David Lacey
CHM | Chairman | 73 | 2019-07-31 |
Julia Gregory
CHM | Chairman | 72 | 2024-05-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/5/26 | Fiscal year | Chief Technology Officer | 13,068 | 0.0126% | ||
| 8/4/26 | Sell | Chief Financial Officer | -4,761 | 0.0046% | ||
| 8/4/26 | Sell | Chief Technology Officer | -4,111 | 0.0040% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.37% | +11.46% | +163.01% | +174.44% | 2.69B | ||
| +4.21% | +25.56% | +77.96% | +104.49% | 70.85B | ||
| -0.21% | +5.33% | +38.61% | +68.64% | 55.41B | ||
| +2.78% | +36.87% | +23.00% | +493.09% | 29.43B | ||
| -0.30% | +13.64% | +54.71% | +6.07% | 24.12B | ||
| -0.93% | +0.60% | -16.89% | -12.00% | 23.31B | ||
| +0.60% | +6.71% | +47.62% | -21.38% | 18.37B | ||
| +7.26% | +14.16% | +221.03% | +393.89% | 16.99B | ||
| 0.00% | +9.69% | +31.01% | +584.59% | 16.1B | ||
| -2.05% | -3.81% | +40.40% | +150.40% | 13.12B | ||
| Average | +1.29% | +354.73% | +68.05% | +194.22% | 27.04B | |
| Weighted average by Cap. | +1.70% | +347.40% | +56.82% | +161.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 755M 654M 611M 559M 1.05B 72.04B 1.07B 7.17B 2.81B 36.04B 2.84B 2.77B 120B | 121M 105M 97.72M 89.31M 168M 11.52B 171M 1.15B 450M 5.76B 453M 444M 19.19B |
| Net income | 368M 319M 298M 272M 513M 35.11B 521M 3.49B 1.37B 17.57B 1.38B 1.35B 58.5B | -174M -151M -141M -129M -242M -16.59B -246M -1.65B -647M -8.3B -653M -639M -27.63B |
| Net Debt | -947M -820M -767M -701M -1.32B -90.35B -1.34B -8.99B -3.53B -45.2B -3.56B -3.48B -151B | -885M -766M -716M -655M -1.23B -84.44B -1.25B -8.4B -3.3B -42.24B -3.32B -3.25B -141B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-10 | US$25.88 | +1.37% | 898,977 |
| 26-08-07 | US$25.53 | +1.23% | 729,851 |
| 26-08-06 | US$25.22 | +0.40% | 805,119 |
| 26-08-05 | US$25.12 | +1.74% | 1,343,967 |
| 26-08-04 | US$24.69 | +6.33% | 1,191,583 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NRIX Stock
Select your edition
All financial news and data tailored to specific country editions

















